rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Gut microbiota in neurologic and visceral diseases
  name:
    name part: Farooqui, Tahira.
  name:
    name part: Farooqui, Akhlaq A.
  name:
    name part: ScienceDirect (Online service)
  type of resource: text
  genre: Electronic books.
  origin info:
    place:
      place term: enk
    date issued: 2021
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: remote
    extent: 1 online resource
  abstract: Gut Microbiota in Neurologic and Visceral Diseases presents readers with comprehensive information on the involvement of microbiota in the pathogenesis of neurological disorders.
  table of contents: Intro -- Gut Microbiota In Neurologic and Visceral Diseases -- Copyright -- Dedication -- Contents -- Contributors -- Preface -- Acknowledgments -- Chapter 1: Gut microbiota: Implications on human health and diseases -- 1 Introduction -- 2 Classification -- 3 Factors affecting the composition of the gut microbiota -- 4 Functional aspects of the gut microbiota -- 4.1 Protection against pathogenic colonization (colonization resistance) -- 4.2 Maintenance of the intestinal epithelium integrity -- 4.3 Modulation of host metabolism -- 4.4 Influence on energy gain and expenditure -- 4.5 Host protection and immune-system development by gut microbiota -- 4.6 Gut microbiota-mediated modulation of host hypothalamic-pituitary-adrenal (HPA) axis -- 4.7 Gut microbiota-mediated alteration in the gut-brain axis (GBA) -- 4.8 Dysbiosis of the gut microbiota -- 5 Manipulation of the gut microbiota -- 6 Conclusion -- References -- Chapter 2: Effect of different types of diet patterns on the gut microbiota composition -- 1 Introduction -- 2 Microbiota-derived metabolites in host tissues -- 3 Effects of long-term consumption of various types of diets on the host -- 4 Effects of long-term consumption of the Western diet -- 5 Effects of long-term consumption of the Mediterranean diet -- 6 Effects of long-term consumption of the vegetarian diet -- 7 Effects of long-term consumption of the ketogenic diet -- 8 Conclusion -- References -- Chapter 3: Importance of fiber in human diet: Contribution of microbiota in human health -- 1 Introduction -- 2 Beneficial effects of dietary fiber consumption on human health -- 3 Gut microbiota and human health -- 4 Effects of gut microbiota-derived metabolite in host tissues -- 5 Role of microbiota-derived short-chain fatty acids -- 6 Role of microbiota-derived trimethylamine and trimethylamine- N -oxide.
  table of contents: 7 Role of tryptophan and its metabolites in metabolism -- 8 Conclusion -- References -- Chapter 4: Importance of fermented foods on human health -- 1 Introduction -- 2 Beneficial effects of fermented foods -- 3 Importance of fermented foods on human health -- 3.1 Consumption of kefir -- 3.2 Consumption of dairy products (yogurt and cheese) -- 3.3 Consumption of kombucha -- 3.4 Consumption of sauerkraut -- 3.5 Consumption of tempeh -- 3.6 Consumption of miso -- 3.7 Consumption of nattō -- 3.8 Consumption of kimchi -- 4 Adverse effects of fermented foods -- 5 Conclusion -- References -- Chapter 5: Contribution of gut microbiota in the pathogenesis of amyotrophic lateral sclerosis and Huntington's disease -- 1 Introduction -- 2 Pathogenesis of familial ALS -- 3 Involvement of the kynurenine pathway in the pathogenesis of sporadic ALS -- 4 Contribution of gut microbiota in the pathogenesis of amyotrophic lateral sclerosis -- 5 Molecular mechanisms contributing to neurodegeneration in Huntington's disease -- 6 Contribution of gut microbiota in Huntington's disease -- 7 Conclusion -- References -- Chapter 6: The gut microbiome in neurodegenerative disorders -- 1 Introduction -- 2 The microbiome: Development and function -- 3 Overview of the gut-brain axis -- 4 Microbiota-gut-brain axis -- 5 Microbiota and neurodegenerative diseases -- 5.1 Microbiota and Alzheimer's disease -- 5.2 Parkinsońs disease -- 5.3 Huntingtońs disease -- 5.4 Amyotrophic lateral sclerosis -- 5.5 Multiple sclerosis -- 6 Role of diet in the microbiome and neurodegenerative disease -- 7 Potential therapies -- 8 Conclusion -- References -- Chapter 7: The contribution of gut microbiota in the pathogenesis of Parkinson's disease -- 1 Introduction -- 2 Gut microbiota dysbiosis in Parkinson's disease.
  table of contents: 3 Microbiota gut-brain axis role in Parkinson's disease -- 4 Synuclein propagation from gut to brain -- 5 Targeting of GBA in Parkinson's disease by probiotics, prebiotics, and/or symbiotics -- 6 Conclusion -- References -- Chapter 8: The contribution of microbiota, cerebral blood flow, and sleep deprivation in the pathogenesis of Alzheimer's d ... -- 1 Introduction -- 2 Factors affecting human gut microbiota -- 3 Effect of microbiota on immune system -- 4 Contribution of microbiota in the pathogenesis of Alzheimer's disease -- 5 Association of cerebral blood flow in Alzheimer's disease -- 6 Contribution of sleep deprivation in the pathogenesis of Alzheimer's disease -- 7 Conclusion -- References -- Chapter 9: Implications of microbiota in the pathogenesis of diabetes mellitus and cardiovascular disease -- 1 Introduction -- 2 Microbiota and diabetes -- 2.1 Type 2 diabetes -- 2.2 Type 1 diabetes -- 3 Microbiota and cardiovascular disease -- 3.1 Atherosclerosis -- 3.2 Acute coronary syndrome -- 3.3 Atrial fibrillation -- 3.4 Heart failure -- 3.5 Arterial hypertension -- 4 Investigative tools -- 5 Treatment and future perspective -- 5.1 Diabetes -- 5.2 Cardiovascular disease -- 6 Conclusion -- References -- Chapter 10: Link between gut microbiome and cardiometabolic diseases -- 1 Introduction -- 2 CMDs -- 3 Effects of diet on gut microbiota -- 4 Gut microbial dysbiosis -- 5 Gut microbial dysbiosis and CMDs -- 5.1 Microbial dysbiosis and obesity -- 5.2 Microbial dysbiosis and diabetes -- 5.3 Microbial dysbiosis and NAFLD -- 5.4 Microbial dysbiosis and atherosclerosis -- 5.5 Microbial dysbiosis and hypertension -- 5.6 Microbial dysbiosis and congestive heart failure -- 6 Conclusion -- References -- Chapter 11: Contribution of microbiota in obesity and obesity-related chronic diseases -- 1 Introduction.
  table of contents: 2 Molecular mechanism of obesity -- 3 Effects of diet and microbiota on chronic diseases -- 4 Obesity, microbiota composition, and type2 diabetes -- 5 Obesity, microbiota, and metabolic syndrome -- 6 Obesity, microbiota, and cardiovascular disease -- 7 Obesity, microbiota, and neurological disorders -- 8 Conclusion -- References -- Chapter 12: Contribution of microbiota in the pathogenesis of ischemic stroke -- 1 Introduction -- 2 Molecular aspects of ischemic stroke -- 3 Contribution of gut microbiota in poststroke injury -- 4 Conclusion -- References -- Chapter 13: Bioactive lipids and gut microbiota interact to regulate health and disease -- 1 Introduction -- 2 Essential fatty acids and their clinical significance -- 3 EFA deficiency suppresses autoimmune diseases: But how and why? -- 4 Gut microbiota -- 5 Potential interaction between EFAs, their metabolites and gut microbiota -- 6 BALs influence gut microbiota -- 7 Conclusion -- References -- Chapter 14: Contribution of gut microbiota and multiple organ failure in the pathogenesis of COVID-19 infection -- 1 Introduction -- 2 COVID-19 infection associated changes in respiratory tract and lungs -- 3 COVID-19 associated changes in gut microbiota and digestive tract -- 4 COVID-19 infection associated changes in cardiovascular system -- 5 COVID-19 associated changes in kidney -- 6 Role of cytokine storm and multiple organ failure in COVID-19 associated death -- 7 Conclusion -- References -- Chapter 15: Contribution of gut microbiota in the pathogenesis of migraine headache -- 1 Introduction -- 2 Theories underlying migraine headache -- 2.1 Vascular theory due to cerebral vasodilation -- 2.2 Cortical spreading depression and migraine -- 2.3 The trigeminovascular system and migraine -- 2.4 Microbiota gut-brain axis and migraine -- 3 Gut microbiota dysbiosis and migraine.
  table of contents: 4 Gastrointestinal disorders, gut microbiota dysbiosis, and migraine -- 4.1 H. pylori infection, gut microbiota dysbiosis, and migraine -- 4.2 Inflammatory bowel disease, gut microbiota dysbiosis, and migraine -- 4.3 IBS, gut microbiota dysbiosis, and migraine -- 4.4 CD, gut microbiota dysbiosis, and migraine -- 4.5 Gastroparesis, gut microbiota dysbiosis, and migraine -- 4.6 Infantile colic, gut microbiota dysbiosis, and migraine -- 5 The gut-brain axis and migraine -- 6 Conclusion -- References -- Chapter 16: Insights on the modulatory role of Ayurveda-based herbal preparations on gut microbiome and neuroprotection -- 1 Introduction -- 2 Gut microbes and brain health -- 2.1 Gut microbiome (GM) -- 2.2 Gut Microbiota and NDD -- 2.3 GM-derived metabolites -- 2.4 GM modulation: Existing approaches -- 2.5 Modulation of GM by phytochemicals -- 3 Evidence of GM involvement in specific NDD -- 3.1 Evidence of involvement GM-PD and HD -- 3.2 Evidence of involvement of GM: Alzheimer's disease (AD) -- 3.3 Flavonoids and GM -- 3.4 Curcumin, GM, and NDD -- 3.5 Spice herbs and neuroprotection -- 4 Ayurveda and NDD -- 4.1 Ayurvedic preparations: Concept of Triphala -- 4.2 Polyherbalism-Polyherbal formulations (PHFs) -- 4.3 Triphala and modulation of GM -- 4.4 Nanoformulations of herbal extracts and NDD -- 5 Recent approaches in microbiome research -- 5.1 Gut microbiome in human populations -- 5.2 Ayurgenomics: Ayurvedic approach -- 6 Conclusions and future perspective -- Acknowledgment -- References -- Chapter 17: The emerging roles of gut microbiome on neurotoxic outcomes: Implications for neurological disorders -- 1 Introduction -- 2 The link between gut and brain -- 3 Neurotoxicity-microbiota interactions -- 3.1 Microbial transformation of neurotoxicants -- 3.2 Microbial regulation of neuroactive metabolites.
  note: edited by Tahira Farooqui and Akhlaq A. Farooqui.
  note: Includes index.
  subject:
    topic: Gastrointestinal system
    topic: Microbiology
  subject:
    topic: Nervous system
    topic: Diseases
    topic: Pathogenesis
  subject:
    topic: Nervous system
    topic: Diseases
    topic: Microbiology
  subject:
    topic: Electronic books
  subject:
    topic: Système nerveux
    topic: Maladies
    topic: Pathogenèse
  subject:
    topic: Système nerveux
    topic: Maladies
    topic: Microbiologie
  subject:
    topic: Livres numériques
  subject:
    topic: e-books
  subject:
    topic: Electronic books
  subject:
    topic: Gastrointestinal system
    topic: Microbiology
  classification: QR171.G29
  classification: 616.80471
  classification: WI 100
  related item:
    identifier: (OCoLC)1225622632
  identifier: 9780128210406
  identifier: 0128210400
  identifier: 9780128210390
  identifier: 0128210397
  identifier: http://proxy.library.tamu.edu/login
  record info:
    record content source: YDX
    record creation date: 210315
    record change date: 20260327170035.8
    record identifier: in00005767938
    language of cataloging:
      language term: eng